Increased vascular permeability after cardiopulmonary bypass in patients with diabetes is associated with increased expression of vascular endothelial growth factor and hepatocyte growth factor

被引:20
|
作者
Emani, Sirisha [1 ]
Ramlawi, Basel [1 ]
Sodha, Neel R. [1 ]
Li, Jian [1 ]
Bianchi, Cesario [1 ]
Sellke, Frank W. [1 ]
机构
[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA
来源
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY | 2009年 / 138卷 / 01期
关键词
FACTOR-I; VEGF; ACTIVATION; HYPOXIA; PROLIFERATION; ANGIOGENESIS; KINASE; CELLS;
D O I
10.1016/j.jtcvs.2008.12.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Several inflammatory mediators such as vascular endothelial growth factor and hepatocyte growth factor are known to play a critical role in the regulation of vascular permeability and angiogenesis. We studied the serum levels of growth factors and gene expression profiles of genes involved in growth factor signaling in the peripheral blood of patients with and patients without diabetes following cardiopulmonary bypass and cardioplegic arrest. Methods: Serum and total RNA were obtained from the blood samples collected from patients with diabetes and matched patients without diabetes (n = 7 patients each) who had coronary artery bypass graft before and 6 hours and 4 days after cardiopulmonary bypass/cardioplegic arrest. The cytokine panel, consisting of growth factors such as vascular endothelial growth factor, hepatocyte growth factor, fibroblast growth factor, and epidermal growth factor, was quantified in patients with diabetes and patients without diabetes before and 6 hours and 4 days post-cardiopulmonary bypass/cardioplegic arrest using multiplex cytokine quantification system. cDNA microarray analysis was performed and fold-change was calculated. Results: Length of hospitalization (10 vs 6 days; P = .04) and weight gain (5 vs 2.5 kg; P = .001) were significantly greater for patients with diabetes compared with patients without diabetes. The serum levels of vascular endothelial growth factor and hepatocyte growth factor were significantly elevated in patients with diabetes when compared with patients without diabetes before versus 6 hours post-cardiopulmonary bypass/cardioplegic arrest. In addition, significantly elevated mRNA expression of hypoxia-inducible factor-1 alpha, cyclic adenosine monophosphate response element binding protein, and E1A binding protein p300 (more than twofold) was observed 4 days post-cardiopulmonary bypass/cardioplegic arrest exclusively in patients with diabetes. Conclusions: The differential profile of gene and protein expression of growth factors and their related genes in patients with diabetes and patients without diabetes could be associated with increased edema and weight gain in patients with diabetes after cardiopulmonary bypass/cardioplegic arrest.
引用
收藏
页码:185 / 191
页数:7
相关论文
共 50 条
  • [41] Effect of Vascular Endothelial Growth Factor on Nasal Vascular Permeability
    Matsune, Shoji
    Ohori, Junichiro
    Yoshifuku, Kousuke
    Kurono, Yuichi
    LARYNGOSCOPE, 2010, 120 (04): : 844 - 848
  • [42] Vascular endothelial growth factor vascular permeability factor mRNA expression in patients with chronic hepatitis C and hepatocellular carcinoma
    Shimoda, K
    Mori, M
    Shibuta, K
    Banner, BF
    Barnard, GF
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1999, 14 (02) : 353 - 359
  • [43] Increased angiogenesis in chronic idiopathic myelofibrosis: vascular endothelial growth factor as a prominent angiogenic factor
    Steurer, Michael
    Zoller, Heinz
    Augustin, Florian
    Fong, Dominic
    Heiss, Simone
    Strasser-Weippl, Kathrin
    Gastl, Guenther
    Tzankov, Alexandar
    HUMAN PATHOLOGY, 2007, 38 (07) : 1057 - 1064
  • [44] Increased Expression of Vascular Endothelial Growth Factor-D Following Brain Injury
    Nag, Sukriti
    Manias, Janet
    Eubanks, James H.
    Stewart, Duncan J.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (07)
  • [45] The circulating vascular endothelial growth factor is only marginally associated with an increased risk for atherosclerosis
    Pauli, Natalia
    Kuligowska, Agnieszka
    Krzystolik, Andrzej
    Dziedziejko, Violetta
    Safranow, Krzysztof
    Rac, Michal
    Chlubek, Dariusz
    Rac, Monika E.
    MINERVA CARDIOANGIOLOGICA, 2020, 68 (04): : 332 - 338
  • [46] Increased intracardiac vascular endothelial growth factor levels in patients with paroxysmal, but not persistent atrial fibrillation
    Scridon, Alina
    Morel, Elodie
    Nonin-Babary, Emilie
    Girerd, Nicolas
    Fernandez, Carmen
    Chevalier, Philippe
    EUROPACE, 2012, 14 (07): : 948 - 953
  • [47] DIFFERENTIAL EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VASCULAR-PERMEABILITY FACTOR) FORMS IN RAT-TISSUES
    BACIC, M
    EDWARDS, NA
    MERRILL, MJ
    GROWTH FACTORS, 1995, 12 (01) : 11 - 15
  • [48] Dual Delivery of Vascular Endothelial Growth Factor and Hepatocyte Growth Factor Coacervate Displays Strong Angiogenic Effects
    Awada, Hassan K.
    Johnson, Noah R.
    Wang, Yadong
    MACROMOLECULAR BIOSCIENCE, 2014, 14 (05) : 679 - 686
  • [49] The function of vascular endothelial growth factor
    Nieves, Bonnie J.
    D'Amore, Patricia A.
    Bryan, Brad A.
    BIOFACTORS, 2009, 35 (04) : 332 - 337
  • [50] Increased ratio of vascular endothelial growth factor to semaphorin3A is a negative prognostic factor in human meningiomas
    Barresi, Valeria
    Tuccari, Giovanni
    NEUROPATHOLOGY, 2010, 30 (05) : 537 - 546